A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders

BACKGROUND: L-carnitine was proposed as a potential treatment for patients diagnosed with an autism spectrum disorder to improve mitochondrial dysfunction, but no prior randomized controlled trials have been conducted. MATERIAL/METHODS: Thirty subjects diagnosed with an ASD were randomly assigned to...

Descripción completa

Detalles Bibliográficos
Autores principales: Geier, David A., Kern, Janet K., Davis, Georgia, King, Paul G., Adams, James B., Young, John L., Geier, Mark R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2011
Materias:
Product Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539542/
https://www.ncbi.nlm.nih.gov/pubmed/21629200
http://dx.doi.org/10.12659/MSM.881792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539542/
https://www.ncbi.nlm.nih.gov/pubmed/21629200
http://dx.doi.org/10.12659/MSM.881792

Ejemplares similares